DarioHealth Corp. (DRIO)
| Market Cap | 31.97M |
| Revenue (ttm) | 28.03M |
| Net Income (ttm) | -29.97M |
| Shares Out | 44.46M |
| EPS (ttm) | -0.57 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 150,755 |
| Open | 0.7100 |
| Previous Close | 0.7174 |
| Day's Range | 0.6700 - 0.7200 |
| 52-Week Range | 0.5011 - 1.5500 |
| Beta | 1.55 |
| Analysts | Strong Buy |
| Price Target | 2.50 (+247.71%) |
| Earnings Date | Aug 7, 2025 |
About DRIO
DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Connect, a solution used to create communities around specific health conditions to increase awareness and education; Dario Mind, a behavioral heal... [Read more]
Financial Performance
In 2024, DarioHealth's revenue was $27.04 million, an increase of 32.86% compared to the previous year's $20.35 million. Losses were -$30.09 million, -45.15% less than in 2023.
Financial StatementsAnalyst Summary
According to 2 analysts, the average rating for DRIO stock is "Strong Buy." The 12-month stock price target is $2.5, which is an increase of 247.71% from the latest price.
News
Dario and GreenKey Health Announce Strategic Commercial Agreement to Transform Chronic Condition Management and Sleep Health for Payers Nationwide
Dario and GreenKey Join Forces to Target $150 Billion Sleep Apnea Market, Addressing 29 Million Americans with Unmet Needs Through Integrated Chronic Care Solution NEW YORK and SAN FRANCISCO , June 26...
Dario Unveils Groundbreaking GLP-1 and AI-Personalization Digital Health Findings
Dario's new research shows sustained outcomes post-GLP-1 for platform users and 89% accuracy in innovative AI blood glucose prediction; the Company is actively working to leverage these findings in co...
DarioHealth Corp. (DRIO) Q1 2025 Earnings Call Transcript
DarioHealth Corp. (NASDAQ:DRIO) Q1 2025 Earnings Conference Call May 14, 2025 8:30 AM ET Company Participants Kat Parrella - Investor Relations Manager Erez Raphael - Chief Executive Officer Lara Dod...
DarioHealth Reports First Quarter 2025 Financial and Operating Results
First quarter revenue of $6.75 million, a 17% increase year-over-year, driven by employer and health plan (B2B2C) growth, and a decrease of 11% sequentially. Gross margin increased to 57.5% compared t...
Dario's Digital Health Solution Demonstrates Effectiveness in New Research Examining Flu Vaccination Awareness in High-Risk Populations
New data, published in JMIR, demonstrates the value of personalized messaging encouraging flu vaccinations in Dario members with diabetes NEW YORK , May 8, 2025 /PRNewswire/ -- DarioHealth Corp. (NASD...
DarioHealth to Report First Quarter 2025 Results on Wednesday, May 14, 2025
Company to host conference call and webcast at 8:30 a.m. Eastern Time NEW YORK , May 7, 2025 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital...
DarioHealth Closes Strategic Refinancing of Existing Debt Facility of up to $50 Million to Provide Additional Operational Flexibility and Support Growth Initiatives
$32.5 million funded at close; up to $17.5 million of additional capital available at the Company's option, subject to the achievement of certain revenue thresholds. Capital from the transaction is ex...
DarioHealth Announces CFO Transition
NEW YORK , April 21, 2025 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) ("Dario" or the "Company"), a leading global digital health company, today announced that Zvi Ben-David , Chief Financial Off...
DarioHealth Collaborates with Leading National Benefit Plan Administrator to Offer Cardiometabolic Solution including a GLP-1 Support Program to Employers
Strategic partnership expands Dario's employer footprint and has already started contributing to recurring revenues in Q1 of 2025 NEW YORK , April 17, 2025 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: D...
Top U.S. Healthcare Institution Deploys DarioHealth's Full Suite, Contributing to 2025 Revenue Growth and Market Expansion
Second major healthcare employer signs with DarioHealth, accelerating growth in 2025 and reinforcing its leadership in AI-powered, clinically validated digital health solutions for chronic condition m...
/C O R R E C T I O N -- DarioHealth Corp./
In the news release, DarioHealth Announces New Blue Cross Blue Shield Agreement, Expanding Health Plan Client Base, issued 06-Feb-2025 by DarioHealth Corp. over PR Newswire, we are advised by the comp...
DarioHealth Corp. (DRIO) Q4 2024 Earnings Call Transcript
DarioHealth Corp. (NASDAQ:DRIO) Q4 2024 Earnings Conference Call March 10, 2025 8:30 AM ET Company Participants Kat Parrella - Investor Relations Manager Erez Raphael - Chief Executive Officer Steven...
DarioHealth Reports Fourth Quarter and Full year 2024 Financial and Operating Results
Full-year 2024 revenue increased by 32.9% to $27.0 million from $20.4 million revenue in 2023. Revenue growth driven by B2B2C channel including employers and health plans resulting in recurring revenu...
Dario Expands Behavioral Health Offerings to Include a Provider Network Through Strategic Arrangement with Rula
The strategic arrangement fuels Dario's B2B2C sales growth, expanding access to over 15,000 providers nationwide NEW YORK , March 7, 2025 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or t...
Dario Signs First Healthcare System as Employer Contract, Expanding Market Presence and Recurring Revenue Growth
Healthcare system collaborates with Dario to offer AI-powered chronic care management solutions as a benefit for their employee base of healthcare workers, expected to contribute to the current total ...
DarioHealth to Report Fourth Quarter and Full Year 2024 Results on Monday, March 10, 2025
Company to host conference call and webcast at 8:30am Eastern Time NEW YORK , March 4, 2025 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital ...
DarioHealth Appoints Healthcare Industry Leader Larry Leisure to Board of Directors
Healthcare innovator and former Accenture executive brings deep industry relationships to advance Dario's AI-driven chronic care platform. NEW YORK , Feb. 27, 2025 /PRNewswire/ -- DarioHealth Corp. (N...
PESG Report: DarioHealth Positions Itself as a Market Leader in the Multi-Billion-Dollar Digital Health Transformation
NEW YORK--(BUSINESS WIRE)---- $DRIO #GLP1--PESG Releases Report: In a healthcare market brimming with potential, DarioHealth Corp. (Nasdaq: DRIO)* is quietly emerging as a standout player, combining c...
DarioHealth Announces $25.6M Private Placement Positioning the Company to Execute on Strategy Aiming to Reach Operational Cash Flow Positive Run Rate by the End of 2025
Significant participation from existing shareholders and accredited healthcare investors, which the company believes underscores confidence in its strategy Financing supports execution of long-term gr...
DarioHealth Expands GLP-1 Weight-Loss Solution, Unlocking New Revenue Streams in Rapidly Growing Multi Billion Dollar Market
NEW YORK--(BUSINESS WIRE)--Market News Alerts Updates that DarioHealth Corp. (Nasdaq: DRIO) is taking another bold step into the rapidly growing weight-loss market, now projected to exceed $100 billio...
DarioHealth Expands GLP-1 Solution with Prescribing Capabilities through Collaboration with MediOrbis, Targeting Employers and Direct-to-Consumer Markets
New collaboration enhances Dario's comprehensive GLP-1 offering with virtual physician management to meet growing demand from employers covering weight-loss medications, opening new revenue streams in...
Dario Signs Four New Employer Contracts Across Full Product Suite
Company expects to reach an estimated total of 25 new client signings in 2024, representing an approximate 35% growth in client base compared to 2023 NEW YORK , Nov. 21, 2024 /PRNewswire/ -- DarioHeal...
DarioHealth Corp. (DRIO) Q3 2024 Earnings Call Transcript
DarioHealth Corp. (NASDAQ:DRIO) Q3 2024 Results Conference Call November 7, 2024 8:30 AM ET Company Participants Kat Parrella - Investor Relations Manager Erez Raphael - Chief Executive Officer Steve...
DarioHealth Reports Third Quarter 2024 Financial and Operating Results
Demonstrated strong improvements in financial performance and business momentum. Q3 revenue of $7.42 million increased 18.7% over Q2 2024 and 111% compared to Q3 2023, driven by expansion of B2B2C rev...
Dario Expands Pharma Collaborations with Global Pharma Leader to Enhance User Engagement
The new platform services subscription contract with a top six U.S. pharma client marks a pivotal shift in Dario's pharma channel, transitioning the business model from milestone-based to recurring se...